MaRS Innovation:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MaRS Innovation - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10444
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MaRS Innovation (MaRS) is a not for profit organization that offers advisory services. The organization’s services include intellectual property, strategy development, business development, operational, marketing resources, project management, financial management, human resources, and investor relations services. It also provides financial support through programs such as medical sciences proof-of-principle program, mars innovation industry access programs, and UTEST programs. MaRS also works with inventors and founding teams to bring discoveries to global markets through industry partnerships, licensing or start-up . The organization serves institutions, universities, research institutes, and MaRS discovery district. It is supported by its member institutions and by the of Ontario through the Ontario Centres of Excellence. MaRS is headquartered in Toronto, Ontario, Canada.

MaRS Innovation – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MaRS Innovation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MaRS Innovation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MaRS Innovation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MaRS Innovation, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MaRS Innovation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MaRS Innovation, Medical Equipment, Deal Details 10
Venture Financing 10
ChipCare Raises USD4 Million in Series A Venture Financing 10
ChipCare Raises US$2 Million In Venture Financing 11
Partnerships 12
MaRS Innovation Enters Into Partnership With Pfizer 12
CML HealthCare Enters Into Agreement With MaRS Innovation 13
Equity Offering 14
XOR-Labs Toronto Raises USD2.2 Million in Private Placement 14
MaRS Innovation – Key Competitors 15
MaRS Innovation – Key Employees 16
MaRS Innovation – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
MaRS Innovation, Medical Equipment, Key Facts 2
MaRS Innovation, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MaRS Innovation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MaRS Innovation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MaRS Innovation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MaRS Innovation, Deals By Market, 2012 to YTD 2018 8
MaRS Innovation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ChipCare Raises USD4 Million in Series A Venture Financing 10
ChipCare Raises US$2 Million In Venture Financing 11
MaRS Innovation Enters Into Partnership With Pfizer 12
CML HealthCare Enters Into Agreement With MaRS Innovation 13
XOR-Labs Toronto Raises USD2.2 Million in Private Placement 14
MaRS Innovation, Key Competitors 15
MaRS Innovation, Key Employees 16
MaRS Innovation, Joint Venture 17

List of Figures
MaRS Innovation, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MaRS Innovation, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MaRS Innovation, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MaRS Innovation, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MaRS Innovation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MaRS Innovation, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MaRS Innovation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MaRS Innovation, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MaRS Innovation:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Productos Medix SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Productos Medix SA de CV (Medix), formerly Laboratories Laif is a provider of research, development, manufacturing and marketing of pharmaceutical chemical products. The company’s products comprise livermade, pylopac, imidex, seronex, feprorex, MZ1, redotex, terfamex, prepram,sinestron, anta …
  • United Community Banks Inc:企業のM&A・事業提携・投資動向
    United Community Banks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Community Banks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Mercy Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Mercy Health, formerly Catholic Healthcare Partners, is a Catholic non-profit health system. It operates through a network of hospitals, clinics, medical centers and urgent care facilities in Ohio and Kentucky to offer healthcare services across various specialties. Mercy Health also provide …
  • Sagent Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sagent Pharmaceuticals Inc (Sagent), formerly Sagent Holding Co, a subsidiary of Nichi-Iko Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and manufactures injectable products. The company offers products such as amikacin sulfate injection, USP, ampicillin and sulbactam f …
  • PolyOne Corp (POL):企業の財務・戦略的SWOT分析
    PolyOne Corp (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • KPS AG (KSC):企業の財務・戦略的SWOT分析
    Summary Kps AG (Kps) is a technology company that offers e-commerce and digital marketing services. The company offers consulting services in the areas of business transformation and process optimization. It offers e-business, wholesale, retail, manufacturing, supply chain management, logistics, ser …
  • Vanda Pharmaceuticals Inc (VNDA):企業の財務・戦略的SWOT分析
    Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cantex Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cantex Pharmaceuticals Inc (Cantex Pharmaceuticals), formerly ParinGenix Inc is a clinical stage biopharmaceutical company. The company discovers and develops proprietary pharmaceuticals for the treatment of cancers and other disorders. Its pipeline products include CX-01 a proprietary combi …
  • CNOOC Limited:企業の戦略・SWOT・財務分析
    CNOOC Limited - Strategy, SWOT and Corporate Finance Report Summary CNOOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Prinzhorn Holding Gmbh
    Prinzhorn Holding Gmbh - Strategy, SWOT and Corporate Finance Report Summary Prinzhorn Holding Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • InVitae Corp (NVTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Invitae Corp (Invitae), formerly Locus Development Inc, is a genetic information company which processes DNA-containing samples, analyzes information about patient-specific genetic variation and generates test reports for clinicians and their patients. The company’s portfolio of diagnostic t …
  • Bahrain Telecommunications Company BSC (BATELCO):企業の戦略的SWOT分析
    Bahrain Telecommunications Company BSC (BATELCO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • International AIDS Vaccine Initiative-製薬・医療分野:企業M&A・提携分析
    Summary International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. It also …
  • Nuh Cimento Sanayi AS (NUHCM):企業の財務・戦略的SWOT分析
    Nuh Cimento Sanayi AS (NUHCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Smith & Nephew plc:企業のM&A・事業提携・投資動向
    Smith & Nephew plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smith & Nephew plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Bio Osmo Berhad:企業の戦略・SWOT・財務情報
    Bio Osmo Berhad - Strategy, SWOT and Corporate Finance Report Summary Bio Osmo Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Immunovia AB (IMMNOV):企業の製品パイプライン分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Harbin Bank Co Ltd:企業の戦略・SWOT・財務分析
    Harbin Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbin Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sun-Rype Products Ltd.:企業の戦略・SWOT・財務分析
    Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆